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Human Wild-Type Tau Interacts with wingless
Pathway Components and Produces Neurofibrillary
Pathology in Drosophila
rather than tau coding sequence (Clark et al., 1998; Hut-
ton et al., 1998; Hong et al. 1998). Moreover, exhaustive
screening has failed to identify tau mutations in AD or the
majority of sporadic or familial cases of FTD (Houlden et
al., 1999); consequently, tau dysregulation by unidenti-
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Department of Neurology fied cis-acting regulatory mutations or other tau-inter-
acting proteins may contribute to tauopathy when it isUniversity of California-Los Angeles
School of Medicine observed in these conditions. Therefore, we created a
Drosophila model of tau-related neurodegeneration that710 Westwood Plaza
Los Angeles, California 90095 does not rely exclusively on mutant tau, but rather on
perturbation of wild-type tau expression.
This model provided us with a sensitized genetic sys-
tem that allowed us to investigate the role of severalSummary
members of the Wnt signaling pathway, including glyco-
gen kinase synthase-3 (GSK-3), in tau-induced neuro-Pathologic alterations in the microtubule-associated
protein tau have been implicated in a number of neuro- degeneration. Components of this pathway, including
-catenin and GSK-3, have been shown to interactdegenerative disorders, including Alzheimer’s disease
(AD), progressive supranuclear palsy (PSP), and fron- with other proteins implicated in AD, such as presenilin
(Killick et al., 2001; Kirschenbaum et al., 2001; Mudhertotemporal dementia (FTD). Here, we show that tau
overexpression, in combination with phosphorylation et al., 2001; Palacino et al., 2001). In addition, GSK-3
is a major effector of tau phosphorylation in vitro (Hangerby the Drosophila glycogen synthase kinase-3 (GSK-3)
homolog and wingless pathway component (Shaggy), et al., 1992; Lovestone et al., 1994) and in vivo (Lucas
et al., 2001). NFT and other pathological forms of tauexacerbated neurodegeneration induced by tau over-
expression alone, leading to neurofibrillary pathology aggregates are composed of filamentous tau that is
hyperphosphorylated on specific serine and threoninein the fly. Furthermore, manipulation of other wingless
signaling molecules downstream from shaggy demon- residues; however, it is unknown whether tau hyperphos-
phorylation is causal or secondary to NFT formation instrated that components of the Wnt signaling pathway
modulate neurodegeneration induced by tau pathology vivo. By manipulation of GSK-3 expression, we were
able to demonstrate enhanced neurodegeneration andin vivo but suggested that tau phosphorylation by
GSK-3 differs from canonical Wnt effects on -cat- NFT-like pathology caused by tau hyperphosphorylation
in the fly eye. These experiments also support a distinctenin stability and TCF activity. The genetic system we
have established provides a powerful reagent for iden- role for the downstream Wnt signaling components -cat-
enin and TCF in modulating tau-induced neurodegener-tification of novel modifiers of tau-induced neurode-




Neurodegeneration Induced by Wild-Type
The identification of disease-causing mutations in the Human Tau
microtubule-associated protein tau in some cases of The cDNA encoding the longest four repeat isoform of
inherited frontotemporal dementia (FDTP-17) demon- human tau (htau4R) was subcloned into a modified GMR
strates conclusively that tau abnormalities can cause expression vector (Hay et al., 1994; Ollmann et al., 2000),
neurodegeneration (Hutton et al., 1998; Clark et al., 1998; and transgenic Drosophila lines were generated. Htau4R
Goedert et al., 1998, 2000). Although tau mutations are transgenic lines (hereafter referred to as gl-tau) demon-
identified in only about 10% of inherited FTD cases, strated an abnormal eye phenotype upon eclosion (i.e.,
a variety of filamentous and nonfilamentous inclusions emergence from the pupal case as adults). As compared
containing tau are identified in many FTD cases, and to wild-type (Figure 1A), the gl-tau eyes were reduced
hyperphosphorylated filamentous tau comprises the in size and displayed a rough phenotype in anterior
NFT that are a pathological hallmark of PSP and AD regions, while posterior aspects appeared normal (Fig-
(Houlden et al., 1999; Goedert et al., 1998; Lee et al., ure 1B). Analysis using scanning electron microscopy
2001). Therefore, understanding the events that modify (SEM) revealed fused and disordered ommatidia with
tau-associated neurodegenerative processes is impor- missing, irregular, and occasional supernumerary mech-
tant to further our understanding of the pathophysiology anosensory bristles. Flies expressing two copies of the
of these diseases and may have relevance for thera- transgene had severely reduced eyes (Figure 1C).
peutics. In order to determine at what stage the onset of the
Many FTD mutations occur in regulatory elements that abnormal phenotype occurs, the larval eye imaginal disc
alter splicing and, thereby, expression of tau isoforms, (the primordium of the adult eye) was examined using
immunohistochemical staining for the neuronal nuclear
protein Elav (Robinow and White, 1988). In third instar1Correspondence: grjackson@mednet.ucla.edu
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Figure 1. Phenotype of gl-tau Transgenic
Eyes
(A–C) SEM images of wild-type Berlin (A) and
transgenic eyes bearing one ([B] yw; gl-tau-
1.1/) or two ([C] yw; gl-tau-1.1) copies of the
tau transgene are depicted. Anterior is to the
left in (A)–(C). Insets are high-magnification
views demonstrating interommatidial bristles.
(D and E) Confocal images ([D] control [yw]
and [E] yw; gl-tau-1.1) of third instar larval eye
imaginal discs are stained with antibodies
against the nuclear proteins Elav (red) and
lamin (green). The morphogenetic furrow is
at the left. Disorganization and cell loss are
apparent in the presence of the tau trans-
genes soon after expression begins ([E]; red:
anti-Elav rhodamine-conjugated anti-rat IgG,
green: anti-lamin  FITC-conjugated anti-
rabbit IgG). Anterior is to the left in (D) and
(E). Arrows, lamin aggregates.
(F and G) Toluidine blue-stained apical tan-
gential sections of wild-type Berlin (F) and
two copy tau-overexpressing retinas ([G], yw;
gl-tau-1.1) show severe tau-induced disorganization of ommatidial architecture with loss of photoreceptor neurons.
(H and I) Longitudinal sections of flies expressing one copy of the tau transgene show severe vacuolization of the medulla (yw; gl-tau-1.1/).
Arrows, vacuoles.
(J) Confocal image of longitudinal cryostat section shows tau immunoreactivity in the retina and brain. Photoreceptor axons in the lamina
and medulla show robust staining using the human tau monoclonal antibody T14 (cn, bw; gl-tau-2.1/).
Scale bars: (A–C), 100 m; (D and E), 2 m; (F and G), 10 m; and (H–J), 20 m.
larval eye discs expressing two copies of the tau trans- -catenin), thus targeting it for degradation via the ubi-
quitin-proteasome pathway (Pai et al., 1997). We assessedgene, early cell loss, and irregularities in differentiating
neurons were apparent soon after tau transgene expres- interactions between tau and the wingless pathway, us-
ing several transgenes and loss-of-function mutations.sion commenced (Figure 1E), compared with the control
shown in Figure 1D. Staining using an antibody directed Transgenes were expressed using the binary GAL4/UAS
system (Brand and Perrimon, 1993), allowing us to targetagainst lamin Dm0 (a homolog of lamin B) (Smith et al.,
1987) demonstrated abnormal accumulation of lamin, their expression to cell populations overlapping with
those expressing tau. In a background heterozygous forwhich is indicative of nuclear envelope breakdown (Fig-
ure 1E), a caspase-mediated process occurring in apo- a hypomorphic allele of shaggy, the tau eye phenotype
was ameliorated, producing larger eyes with a moreptotic nuclei (Oberhammer et al., 1994; Lazebnik et al.,
1995; McCall and Steller, 1998). Loss of photoreceptor normal ommatidial array except at the most anterior
margin of the eye (data not shown). This effect wasneurons and disorganization of the normal (Figure 1F)
ommatidial architecture is observed in flies expressing subtle when the effect of the shaggy loss-of-function
was assessed in conjunction with one copy of the tautwo copies of the tau transgene (Figure 1G). Analysis
of the underlying medulla, the second optic ganglion, transgene, but was dramatic when the transgene copy
number was increased; two copies of gl-tau produceddemonstrated numerous vacuoles (Figures 1H and 1I).
Vacuolization has also been observed in a fly model of a severely reduced eye phenotype (Figure 2A), which
was dramatically suppressed in a background heterozy-neurodegeneration due to overexpression of wild-type
or the FTD-causing R406W tau mutation, where the ap- gous for a loss-of-function mutation in shaggy (Figure
2B). We employed a pan-neural driver that had beenpearance of vacuoles was correlated with neurodegen-
eration (Wittmann et al., 2001). Here, comparison of the exploited previously to examine effects of shaggy over-
expression in the eye (Ahmed et al., 1998), the elav-pattern of vacuolization with that of tau expression in
the medulla was assessed using T14, (Kosik et al., 1988) GAL4C155 line (Lin and Goodman, 1994). In trans to elav-
GAL4, UAS-shaggy had no visible external phenotypea monoclonal antibody recognizing an amino terminal
epitope of human tau (Figure 1J). Vacuolization was most other than mildly disordered bristles (data not shown).
In the presence of gl-tau, however, shaggy exerted aprominent in the medulla, where tau immunoreactivity
was confined to axons of photoreceptors R7 and R8. dramatic effect. Coexpression of tau throughout the ret-
ina, in combination with pan-neural expression of
shaggy, resulted in a markedly reduced eye with com-GSK-3/shaggy Modulates Tau-Induced
plete loss of normal ommatidia and the majority of bris-Neurodegeneration and NFT-Like Aggregates
tles (Figure 2D).A major source of tau phosphorylation in brain is the
We examined the retinal localization of tau coex-serine-threonine kinase, GSK-3, the human homolog
pressed with shaggy using the monoclonal antibodyof Drosophila shaggy/zeste white-3 (Perrimon and Ma-
AT100, which recognizes a phosphorylated epitopehowald, 1987). Shaggy is a component of the wingless
unique to tau within PHF (Matsuo et al., 1994). AT100signaling pathway (Willert and Nusse, 1998) and serves
to phosphorylate Armadillo (the Drosophila homolog of staining is specific for intraneuronal and extraneuronal
Tau Interacts with wingless Pathway in Drosophila
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Figure 2. shaggy Loss-of-Function Sup-
presses, Whereas Pan-Neural Overexpres-
sion of shaggy Enhances, the Tau Rough Eye
Phenotype and Results in the Formation of
NFT-Like Fibrillar Inclusions
(A–D) SEM images of yw; gl-tau-1.1/; gl-tau-
2.1/ (A), sgg1/; gl-tau-1.1/; gl-tau-2.1/
(B), yw; gl-tau-1.1/ (C), and elav-GAL4/;
gl-tau-1.1/; UAS-sgg/ (D) show suppres-
sion of the two copy tau phenotype in a back-
ground heterozygous for a shaggy mutation
and enhancement with pan-neural overex-
pression of shaggy. Anterior is to the left in
(A–D).
(E–H) Confocal analysis of cryostat sections
using an antibody recognizing phosphory-
lated PHF-tau. (E) (elav-GAL4/; cn, bw; gl-
tau-2.1/TM6B) shows negligible staining of
phosphotau in the retina, but (F)–(H) (elav-
GAL4/; cn, bw; gl-tau-2.1/UAS-sgg) show
aggregates of phosphorylated tau with pan-
neural shaggy expression. Red: AT100 
Cy3-conjugated anti-mouse IgG. Green:
DAPI. Nuclear disorganization accompanies
the more severe neurodegenerative pheno-
type. (G) Neurofibrillary aggregates show
AT100 immunoreactivity in dystrophic neu-
rites and cell bodies. Box, enlargement
shown in (H). In (F), the section is more later-
ally oriented than shown in (G) and (H).
Scale bars: (A–D), 100 m; (E and F), 20 m;
and (G and H), 10 m.
NFT in AD, recognizing a compound phosphorylated to those extracted from the AD brain, were observed
(Figures 3B–3D; Crowther 1991; Crowther et al. 1992).epitope in NFTs, but not tau in its native fetal or adult
state or in pretangles (Hoffmann et al., 1997; Zheng- The filament shown in Figure 3B is approximately 410
nm long, 30 nm wide at its thickest point, and has aFischhofer et al., 1998; Augustinack et al., 2002). No
staining for AT100 was observed in the wild-type (data periodicity of 45 nm; these measurements are within the
range of 75 to 550 nm length, 8 to 40 nm width, and 40not shown), whereas traces of diffuse staining were ob-
served in tau transgenic eyes (Figure 2E). Strikingly, in to 80 nm periodicity observed in human PHF. Straight
filaments (another form of pathological filamentous tau),flies coexpressing shaggy and tau within photoreceptor
neurons, abundant discrete flame-shaped and fibrillar which are considered a structural variant of PHF
(Crowther 1991), were also observed to be within theaggregates were observed throughout the retina and
underlying lamina and medulla (Figure 2F). Dystrophic size ranges observed in AD. Three straight filaments
from fly brain shown in Figures 3C and 3D are approxi-neurites and cell bodies containing hyperphosphory-
lated tau with morphology reminiscent of NFT were ob- mately 160 to 210 nm long and 20 nm wide, and the
filament derived from postmortem AD brain extractedserved with AT100 staining (Figures 2G and 2H).
The appearance of fibrillar phosphotau aggregates concurrently with the fly heads is approximately 290
nm long and 20 nm wide (Figure 3E), consistent withwith shaggy misexpression correlated with increased
tau immunoreactivity with AT100 using immunoblots of previous measurements in postmortem brain. Thus,
phosphorylation of human tau by the Drosophila GSK-3gl-tau heads (Figure 3A). Minimal AT100 tau immunore-
activity was observed in the gl-tau flies alone, whereas homolog Shaggy resulted in the formation of neurofibril-
lary pathology, including straight filaments and PHF,a more abundant signal was observed with heads coex-
pressing gl-tau and shaggy, correlating with the immu- whereas these structures were not observed in flies
overexpressing tau alone.nohistochemical presence of fibrillar aggregates of tau.
Electron microscopy of insoluble extracts was per- Given the enhanced rough eye phenotype and ap-
pearance of neurofibrillary-like aggregates containingformed to ascertain the conformation of the filamentous
tau-containing aggregates. Filament formation was not hyperphosphorylated tau in flies coexpressing tau and
shaggy, we sought to determine the relationship be-observed in the wild-type background or in flies express-
ing gl-tau alone. In the presence of both the tau and tween the appearance of AT100 immunoreactivity and
neurodegeneration. In third instar larval eye discs ex-shaggy transgenes, however, filamentous structures, in-
cluding PHF showing a characteristic periodicity similar pressing one copy of gl-tau, only subtle irregularities
Neuron
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Figure 3. Coexpression of shaggy and Tau
Produces Increased AT100 Signal on Immu-
noblots and Abnormal Filaments by Electron
Microscopy
(A) Immunoblot, using heads of flies express-
ing tau either alone (lane 2) or with shaggy
(lane 3), shows comparable levels of tau as
assessed using a phosphorylation-indepen-
dent antibody (T14). Using a phosphotau anti-
body (AT100), minimal signal is observed with
tau alone (lane 5), but increased signal is seen
in the presence of both tau and shaggy (lane
6). Quantitation of the AT100 immunoreactivity
in two independent pools each of shaggy 
gl-tau and gl-tau fly heads normalized for T14
signal revealed an increase of more than
2-fold (2.07  0.33, mean  SD) in AT100
immunoreactivity in shaggy  gl-tau flies, as
compared to those expressing tau alone. No
signal was observed in the wild-type back-
ground with either antibody (lanes 1 and 4).
A longer exposure was used for AT100, as
compared to T14, for the figure. Genotypes are as follows: lanes 1 and 4, wild-type Berlin; lanes 2 and 5, elav-GAL4/ gl-tau-1.1/; TM6B/
; and lanes 3 and 6, elav-GAL4/; gl-tau-1.1/; UAS-sgg/.
(B–D) Appearance of filaments derived from flies expressing both tau and shaggy (elav-GAL4/; gl-tau-1.1/; UAS-sgg/) is depicted. The
PHF are all shown at the same scale (bar: 200 nm, [E]).
were observed using double staining for lamin and Elav rodegeneration. Focal aggregates of AT100 immuno-
reactivity were apparent soon after tau expression com-(Figure 4A). In flies coexpressing tau and shaggy, how-
ever, focal aggregates of AT100-positive signal were menced; neurodegeneration was apparent in the larval
eye disc but became progressively more severe in pupaesurrounded by areas of absent Elav staining with either
abnormal or absent lamin staining, indicating ongoing and adults.
nuclear breakdown and cell death (Figure 4B). However,
massive accumulation of lamin, such as that observed -Catenin/armadillo and TCF Modify Tau-Induced
Neurodegenerationwith two copies of gl-tau (Figure 1E), was not observed
with one copy in combination with shaggy. We then Given the success obtained in modifying the tau pheno-
type via manipulation of shaggy expression, the effectsexamined the appearance of phosphorylated tau and
the morphology of the eye disc in a midpupal stage of two other wingless pathway components downstream
of shaggy were assessed: armadillo, the fly homolog of(70%). Tangential views showed mild abnormalities in
ommatidial orientation in the presence of gl-tau, but -catenin (Riggleman et al., 1989), and pangolin/dTCF,
the fly homolog of TCF (Brunner et al., 1997). Whenotherwise the eye discs were fairly normal (Figure 4C).
Only trace AT100 immunoreactivity was observed. In wingless signaling occurs, Shaggy activity is inhibited,
decreasing Armadillo phosphorylation and facilitatingthe presence of both tau and shaggy, however, more
severely malformed rhabdomeres were observed (Fig- its translocation into the nucleus to act as a transcrip-
tional coactivator of dTCF (Willert and Nusse, 1998). Ifure 4D). Focal AT100 immunoreactivity was observed
along the posterior aspects of the rhabdomeres, where potentiation of the gl-tau rough eye phenotype by
shaggy overexpression occurred via antagonism of themicrotubules are known to localize (Fan and Ready,
1997). Lamin staining showed a more intense intra- wingless pathway, loss-of-function mutations in arma-
dillo would have the opposite effect of those in shaggy,nuclear pattern rather than the distinct inner nuclear
membrane appearance seen in the absence of shaggy, since the former would suppress, whereas the latter
would activate, wingless signaling. Instead, we ob-indicating ongoing apoptosis in the pupal stage. Finally,
we compared the appearance of the adult retina of gl-tau served that two mutations in armadillo suppressed the
tau phenotype, resulting in restoration of the eye to neartransgenic eyes in the absence (Figure 4E) and presence
(Figure 4F) of overexpressed shaggy using toluidine wild-type size with a more regular external appearance,
except at the anterior margin (Figures 5A–5C). In orderblue-stained tangential sections. In the absence of
shaggy, minor abnormalities of ommatidial orientation to assess the effect of armadillo gain-of-function, stabi-
lized arm (UAS-arm.S10; Pai et al., 1997) was expressedwere observed, with occasional missing rhabdomeres
and fused ommatidia (Figure 4E). In the presence of under sevenless (sev)-GAL4 (Brunner et al., 1994) control
in order to minimize phenotypic effects in the absenceshaggy, ommatidial architecture was highly irregular,
with severely misoriented rhabdomeres. The normal pat- of tau by restricting expression to cone cells and a sub-
set of photoreceptor neurons. The sev-GAL4 drivertern of pigment surrounding each ommatidium (e.g., in
Figures 1F and 4E) was lost, with only traces of pigmen- alone has no effect on the gl-tau phenotype (Figure 5D).
A slightly different stabilized form of armadillo inducestation. Vacuolization of the retina was also apparent.
Taken together, these findings indicate that tau hyper- death of photoreceptor neurons when expressed under
control of sevenless (Ahmed et al., 1998). Under sev-phosphorylation induces early onset, progressive neu-
Tau Interacts with wingless Pathway in Drosophila
513
Figure 5. armadillo Loss-of-Function Mutations Suppress, Whereas
Misexpression of Stabilized armadillo Enhances, the gl-tau Phe-
notype
(A–C) SEM images of yw; gl-tau-1.1/ (A), arm1/; gl-tau-1.1/ (B),
and arm4/; gl-tau-1.1/ (C) show suppression of the tau phenotype
in flies heterozygous for two different armadillo mutations.
(D–F) Images of yw/y; gl-tau-1.1/sev-GAL4(S) (D), UAS-arm.S10/y;
sev-GAL4(S)/ (E), and UAS-arm. S10/y; gl-tau-1.1/sev-GAL4(S) (F)
show a mildly reduced eye with disordered bristles with misexpres-
sion of stabilized armadillo alone, which is enhanced by coexpres-
sion with tau, yielding a severely reduced eye with complete loss
of normal ommatidia and bristles.
Scale bar: 100 m.
enless control, arm.S10 expression resulted in a mildly
reduced eye with disordered bristles (Figure 5E). The
gl-tau and stabilized armadillo transgenes showed a
synergistic effect, producing markedly reduced eyesFigure 4. Overexpression of shaggy Results in Early Tau Phosphor-
ylation and Exacerbation of Neurodegeneration with complete loss of ommatidial borders and bristles
(Figure 5F). Thus, perturbation of armadillo expression(A–B) Third instar larval eye discs stained with anti-lamin (blue; Cy5-
conjugated anti-rabbit IgG), anti-Elav (red; rhodamine-conjugated showed effects opposite those expected if the patholog-
anti-rat IgG), and AT100 (green; FITC-conjugated anti-mouse IgG) ical effects of shaggy occurred via Armadillo phosphory-
are depicted. Irregularities of lamin and Elav staining indicating on- lation and its subsequent downregulation, rather than
going apoptosis, as well as appearance of discrete phosphotau
via an independent, direct effect of shaggy on tau phos-aggregates, are apparent in discs expressing both tau and shaggy
phorylation.([B], elav-GAL4/; gl-tau-1.1/; UAS-sgg/). No AT100 staining is
observed in the absence of the shaggy transgene, and only minor We next evaluated the effects of altering dTCF expres-
irregularities in nuclear staining are observed ([A], elav-GAL4/; gl- sion on the tau-induced phenotype. A loss-of-function
tau-1.1/; TM6B/). mutation in dTCF resulted in subtle amelioration of the
(C and D) Midpupal (70%) eye discs stained with phalloidin-rhoda- phenotype, with the rough aspect apparent only in more
mine (red), lamin (blue; Cy5-conjugated anti-rabbit IgG), and AT100
anterior portions of the eye (Figures 6A and 6B). Overex-(green; FITC-conjugated anti-mouse IgG) are shown in (B) and (C).
pression of dTCF using both the elav- and sev-GAL4Minor irregularities in ommatidial orientation are observed in the
absence of the shaggy transgene with only traces of AT100 staining drivers was lethal, so a weaker version of the sev-GAL4
(C), elav-GAL4/; gl-tau-1.1/; TM6B/). In the presence of overex- driver (Therrien, et al., 1999) was used. Under control
pressed shaggy (D), more irregularities in the rhabdomere structure of this sev-GAL4 driver, UAS-dTCF showed a normal
are observed with abnormal lamin staining indicating nuclear enve- external phenotype other than subtle bristle abnormali-
lope breakdown. Intense AT100 staining is observed along posterior
ties (data not shown). In the presence of both the tauaspects of rhabdomeres (arrows; elav-GAL4/; gl-tau-1.1/; UAS-
and dTCF transgenes, an enhanced rough appearancesgg/).
(E and F) Toluidine blue-stained apical tangential sections of adult to the anterior aspect of the eye was apparent, with
retina. In the absence of overexpressed shaggy (E), subtle irregulari- fusion, pitting, and collapse of ommatidia, as well as
ties in ommatidial orientation are observed, with occasional fused loss and irregularities of bristles (Figures 6C and 6D).
ommatidia and missing rhabdomeres (elav-GAL4/; gl-tau-1.1/; Thus, manipulation of dTCF and armadillo showed com-
TM6B/). When shaggy is overexpressed (F), ommatidia become
parable effects, with loss-of-function mutations sup-highly disorganized, with abnormally oriented rhabdomeres and pig-
pressing and overexpression enhancing the tau phe-mentation (elav-GAL4/; gl-tau-1.1/; UAS-sgg/).
Scale bars: (A and B), 3 m and (C–F), 10 m. notype.
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enable genetic screening for modifiers of tau-associated
neurodegeneration. We tested for genetic interactions
between tau-induced neurodegeneration and the Wnt
pathway using GSK-3 and two additional components,
-catenin/armadillo and dTCF, which are downstream
of GSK-3. Overexpression of wild-type htau4R in Dro-
sophila resulted in degeneration without apparent accu-
mulation of NFT, as observed in previous models (Wil-
liams et al., 2000; Wittmann et al., 2001). However, we
observed that tau hyperphosphorylation by the Drosophila
GSK-3 homolog Shaggy exacerbated tau-induced neu-
rodegeneration, resulting in the formation of NFT-like
filamentous tau aggregates, thus showing a causal rela-
tionship between tau hyperphosphorylation and neurofi-
brillary pathology in vivo. These findings suggest that
tau phosphorylation by the fly GSK-3 homolog has a
direct influence on the aggregation of tau in vivo, which
is likely independent of its classical Wnt role (i.e., enhance-
ment of -catenin degradation). These data furtherFigure 6. dTCF Loss-of-Function Mutation Suppresses, Whereas
establish the Wnt pathway as a mediator of tau-inducedMisexpression of dTCF Enhances, the gl-tau Phenotype
neurodegeneration and demonstrate that factors other(A and B) SEM images of yw; gl-tau-1.1/ (A) and ; gl-tau-1.1/
than phosphorylation can modulate neurodegeneration;; dTCF2/ (B) show that the tau phenotype is mildly suppressed
in eyes heterozygous for a null dTCF mutation. associated with tau dysregulation.
(C and D) Images of w; sev-GAL4 (W)/; gl-tau-2.1/ (C) and w;
sev-GAL4 (W)/UAS-dTCF; gl-tau-2.1/ (D) show enhancement of
the tau eye phenotype at the anterior margin of the eye in flies A Distinct Role for the Wnt/wingless Pathway
overexpressing dTCF. Overexpression of dTCF alone (data not
The enhancement of tau-induced neurodegenerationshown) yields essentially normal eyes with subtle bristle abnormali-
observed in conjunction with GSK-3misexpression ledties (w; sev-GAL4 (W)/UAS-dTCF).
us to assess the effects of manipulating expression ofScale bars: (A and B), 100 m and (C and D), 50 m.
-catenin/armadillo and TCF, which are downstream of
GSK-3 in the canonical Wnt signaling pathway. The
Wnt pathway, originally described as the wingless path-Inhibitors of Apoptosis Suppress Tau-Induced
Neurodegeneration way in Drosophila, is crucial for axis formation and re-
gionalization of the vertebrate body and nervous systemThe effects of three well-characterized anti-apoptotic
genes, DIAP-1, DIAP-2 (Hay et al., 1995), and P35 (Hay (Cadigan and Nusse, 1997; Peifer and Polakis, 2000).
The activity of GSK-3 is inhibited as a consequenceet al., 1994), on the tau phenotype were then assessed.
Each of the three apoptotic inhibitors tested partially of Wnt signaling (Cadigan and Nusse, 1997; Dale, 1998).
In the absence of the Wnt signal, GSK-3 phosphoryla-suppressed the gl-tau phenotype (Figure 7A), resulting
in restoration of the eye toward wild-type size with a tion of -catenin leads to its degradation and thus im-
pairs the ability of -catenin to serve as a coactivatorless rough external appearance (Figures 7B–7D). The
ability of the apoptotic inhibitor transgenes to suppress of the transcription factor TCF. Therefore, if GSK-3
overexpression were exerting its tau-modifying effectthe tau phenotype was incomplete but comparable to
that of the heterozygous armadillo mutations. These indirectly via enhancement of -catenin phosphoryla-
tion, loss of -catenin or TCF function would mirror thedata, in conjunction with abnormalities observed in the
pattern of nuclear lamin staining, strongly support a role effect of GSK-3 overexpression. In contrast, increased
-catenin or TCF activity, as it occurs following Wntfor apoptosis in tau-induced neurodegeneration.
binding to its receptor, would be expected to exert an
effect opposite to that of GSK-3 overexpression.Discussion
This was not observed. Instead, increased expression
of either -catenin/armadillo or TCF enhanced the tau-Here, human tau was overexpressed in the Drosophila
eye to create a model of neurodegeneration based on induced neurodegenerative phenotype, whereas loss-
of-function mutations in -catenin/armadillo or TCFperturbation of wild-type tau expression, as well as to
Figure 7. Inhibitor of Apoptosis Proteins
Suppress the gl-tau Phenotype
As compared to flies expressing one copy of
the tau transgene alone ([A] yw; gl-tau-1.1/),
coexpression of DIAP1 ([B] GMR-DIAP-1/;
gl-tau-1.1/), DIAP-2 ([C] yw; gl-tau-1.1/;
GMR-DIAP2), or P35 ([D] yw; gl-tau-1.1/;
GMR-P35/) suppresses the phenotype, re-
storing eye size toward normal. Scale bar:
100 m.
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repressed it. Thus, results of the manipulation of two one copy of gl-tau (Figure 1B, inset). We surmise that
these developmental effects may also be due to interac-targets downstream of GSK-3 in the Wnt pathway are
most consistent with the notion that when overex- tions with Wnt signaling. In the Drosophila eye, ectopic
wingless expression suppresses interommatidial bristlepressed in the context of human tau dysregulation, GSK-
3/shaggy is not exerting its primary effect in this model formation by repressing achaete expression, using a
pathway requiring armadillo (Cadigan and Nusse, 1997).via the canonical Wnt pathway but, rather, via direct tau
hyperphosphorylation (Godemann et al., 1999; Ishiguro Sensory organ precursors in the pupal eye disc are se-
lected to form interommatidial bristles. Eye-specificet al., 1993; Mandelkow et al., 1992; Mulot et al., 1994).
If their effects are indeed independent, as suggested overexpression of the intracellular domain of E-cadh-
erin, which attracts Armadillo to adherens junctions andby the current observations, one might also expect
-catenin/armadillo and GSK-3/shaggy overexpres- thus inhibits its signaling function (Sanson et al., 1996),
also generates supernumerary bristles (Greaves et al.,sion or loss-of-function mutations to be additive in the
gl-tau background, an outcome that can be assessed 1999). The increase in severity of neurodegeneration
observed in the current model of tau overexpressionin future studies. Further support for these conclusions
comes from the observation of a -catenin-indepen- follows an anterior-posterior gradient that parallels the
pattern of wingless expression in the larval eye disc (Madent, proapoptotic effect of GSK-3 in primary cortical
neuronal cultures (Hetman et al., 2000). The predomi- and Moses, 1995), again consistent with the modulatory
effects of Wnt signaling observed here. These devel-nance of the direct effect of shaggy phosphorylation of
tau over downstream Wnt pathway signals in the current opmental interactions between pathological tau expres-
sion and the Wnt pathway, a critical player in CNS re-model may be attributed to a recently identified require-
ment for -catenin priming by casein kinase I phos- gionalization, are also supportive of the idea that
developmental perturbations may underlie the regionalphorylation prior to its phosphorylation by GSK-3 and
subsequent degradation (Liu et al., 2002) It will now be vulnerability observed in focal neurodegenerative syn-
dromes, such as FTD (Geschwind and Miller, 2001;important to examine the effects of shaggy overexpres-
sion on Armadillo phosphorylation and stability more Geschwind et al. 2001).
closely, with attention to a potential role for casein ki-
nase I priming in the gl-tau model. The Role of Phosphorylation in Fibrillar
Previous work has shown a role for the Wnt pathway Tau Aggregation
and, specifically, -catenin in apoptosis in the nervous A large body of literature demonstrates that tau present
system in Drosophila (Ahmed et al., 1998; Freeman and in many forms of insoluble pathological aggregates, in-
Bienz, 2001) and the mouse (Hasegawa et al., 2002). cluding NFT in AD and FTD, is abnormally phosphory-
Therefore, the modulatory effects of -catenin and TCF lated on specific serine and threonine residues detected
on the neurodegeneration observed here suggested a by AT100 and other antibodies (Goedert et al., 1998;
function for apoptotic cell death in degeneration associ- Lee et al., 2001). Among these antibodies, the AT100
ated with gl-tau. The role of apoptosis in tau-induced epitope defines NFT-tau most unambiguously, since it
neurodegeneration was confirmed by changes in lamin does not react with tau in the normal brain or tau that
staining, indicating breakdown of the nuclear envelope, is in a pretangle, nonfilamentous confirmation (Zheng-
which is a typical feature of apoptosis in Drosophila and Fischhofer et al. 1998; Augustinack et al., 2002). Thus,
mammalian systems (Oberhammer et al., 1994; Lazebnik the presence of the AT100 epitope that has been shown
et al., 1995; McCall and Steller, 1998). This was further to be specific for tau in the intracellular and extracellular
demonstrated by amelioration of tau-induced cell death tangle stage in AD (Augustinack et al., 2002) strongly
by overexpression of three anti-apoptotic genes. Recent supports the presence of NFT-like inclusions in this fly
work demonstrates a role for GSK-3 phosphorylation model. EM studies further strengthen this assertion by
of tau in neuronal apoptosis in rat brain (Elyaman et al., demonstrating the presence of PHF and straight fila-
2002). Apoptosis has also been implicated in neurode- ments, the ultrastructural components of NFT (Kosik et
generation in cell lines expressing tau harboring several al. 1988; Lee et al. 2001), both of which have a size and
different FTDP-17-causing mutations (Furukawa et al., periodicity within the ranges observed in human disease
2000), in a mouse model of FTDP-17-expressing mutant (Crowther 1991; Crowther et al., 1992).
tau (Gotz et al., 2001), and in autopsy tissue from FTD Pathological tau hyperphosphorylation and NFT for-
patients (Su et al., 2000). These studies support the mation have also been observed in mice overexpressing
relevance of the current findings in Drosophila to FTD the FTDP-17-causing P301L mutation (Lewis et al. 2000).
in humans and other models of tauopathy. Not all cases However, it remains controversial whether this phos-
of FTD involve tau (Morris et al., 2001; Lee et al. 2001), phorylation is a primary event or a secondary conse-
so whether apoptosis is a major mechanism of neuronal quence of altered tau conformation in AD and other
death in non-tau-related FTD awaits further investi- neurodegenerative conditions, despite evidence that
gation. phosphorylation directly precedes filament formation in
vitro. GSK-3, by virtue of its role as a major tau kinase
(Lovestone et al., 1994; Sperber et al., 1995; Zheng-The Effect of Tau Misexpression on Neural
Development and Cell Fate Fischhofer et al., 1998), its formation of a complex with
tau in the microtubule fraction from bovine brain (SunExamination of the effects of moderate tau overex-
pression suggests that the gl-tau phenotype is due to et al. 2002), and its colocalization with phosphorylated
tau during development (Brion et al., 2001) is a leadingsignificant alterations in cell fate decisions, as well as
progressive neurodegeneration. As many as four inter- candidate for initiating pathologic tau hyperphosphory-
lation. The data presented here demonstrate that hyper-ommatidial bristles were observed in eyes expressing
Neuron
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phosphorylation of tau by GSK-3 accelerates neurode- to abnormal phosphorylation of tau, rather than NFT,
per se. Thus, the formation of NFT or other large visiblegeneration and causes fibrillary tau-immunoreactive
inclusions in vivo, confirming previous in vitro studies tau aggregates may reflect a relatively late or severe
stage in the neurodegenerative process. However, since(Wille et al., 1992; Crowther et al., 1992; Lovestone et
al., 1994; Sperber et al., 1995; Brion et al., 2001). NFT are a defining characteristic of several neurodegen-
erative disorders (including AD and PSP) and are a ro-Enhancement of tau aggregation following GSK-3
phosphorylation was also observed in a mouse model bust and scorable marker, neurofibrillary pathology
(such as that described here) is likely to prove useful inof inducible GSK-3 overexpression in the presence of
wild-type murine tau in which increased insoluble tau screening for disease modifiers. It is unlikely that any
single experimental model will faithfully recapitulate alland pretangles were observed without NFT per se (Lu-
cas et al., 2001). This observation agrees with data re- pathologic features of complex neurodegenerative con-
ditions in humans. Nonetheless, these findings, using aported here, demonstrating that the combination of
GSK-3 overexpression and wild-type tau dysregulation genetically pliable organism, provide impetus for ex-
tending and confirming our observations in mammalianproduces neurofibrillary pathology. Axonopathy, tau
hyperphosphorylation, and pretangle formation have systems.
also been observed in mice overexpressing wild-type
htau4R in the absence of GSK-3 activation, consistent Comparison to Previous Fly Models
with the mild tau phosphorylation observed in gl-tau The neurodegenerative phenotype observed in this
flies. Surprisingly, constitutive GSK-3 activation and study with wild-type tau overexpression appeared as
wild-type 4R tau phosphorylation actually ameliorated severe as that seen previously with mutant tau overex-
the pathology in another transgenic model (Spittaels et pression (Wittmann et al., 2001). This may, in part, reflect
al., 2000). This finding contrasts with other in vitro and differences in the promoter systems employed, resulting
in vivo studies, including that reported here, which dem- in tau misexpression in a more restricted subset of cells
onstrate enhancement of neurodegeneration coincident within the eye, as reported by Feany and coworkers
with tau hyperphosphorylation (Anderton et al., 2000; (Wittmann et al., 2001). That neurodegeneration of
Lee et al., 2001). This apparent contradiction may be roughly equivalent severity is observed with wild-type
due to differences in promoters, expression levels, or and mutant human tau overexpression in the Drosophila
genetic background effects. eye argues against the notion that neurodegeneration
It is unknown whether tau phosphorylation by kinases observed with mutant tau overexpression is a mutation-
other than GSK-3 (e.g., Cdk5) has similar conse- specific effect (Wittmann et al., 2001). Our data would
quences to those observed here; the role of these and predict that more widespread expression of wild-type
other factors (such as phosphatases) can now be inves- tau under control of the GMR-GAL4 driver, as opposed
tigated using this experimental paradigm. Nor is it to the elav-GAL4 driver, would produce rough eyes irre-
known whether the amyloid-induced tau hyperphos- spective of whether the tau transgene is mutant or wild-
phorylation and NFT formation observed recently in mu- type.
tant tau transgenic mice (Gotz et al., 2001; Lewis et al., Recently, the sequence and expression pattern of the
2001) occurs via tau phosphorylation by GSK-3 or an Drosophila homolog of tau have been reported (Heidary
alternate pathway. However, these data identify GSK-3 and Fortini, 2001). However, information as to effects of
as a potential candidate for mediating amyloid-induced mutations in or overexpression of fly tau is not available.
NFT formation in the presence of tau dysregulation. We have not observed crossreactivity of human tau anti-
bodies with endogenous fly proteins, consistent with the
findings of others (Wittmann et al., 2001). It is unknownThe Role of NFT Formation in Neurodegeneration
Observations of neurodegenerative changes without whether interaction with endogenous fly tau plays a role
in human tau-induced neurodegeneration and tau ag-NFT in humans harboring tau mutations (Houlden et al.,
1999; Morris et al., 2001) and in transgenic Drosophila gregation in our model, but this possibility can now be
examined.(Wittmann et al., 2001; the present study) call into ques-
tion the causal role of tau aggregation and NFT formation Neurodegenerative disease-causing mutations that
are thought to induce a toxic gain-of-function are, inin neurodegeneration. The circumstantial association of
NFT with early morphological changes in neurons from many respects, excellent candidates to be modeled in
Drosophila (Fortini and Bonini, 2000; Jackson et al.,postmortem human AD brains has long suggested a
causal role for NFT formation in AD (Braak and Braak, 1998; Jackson 2000; Muqit and Feany, 2002). On the
other hand, expression of nonmutant counterparts of1994).While definitive answers are beyond the scope of
any single investigation, our results, as well as those disease-associated proteins may also provide important
insights into neurodegenerative mechanisms. For exam-of Feany and colleagues (Wittmann et al., 2001), may
provide some important clues. ple, pan-neural expression of wild-type -synuclein pro-
duces Lewy bodies and neurodegeneration (Feany andWe observed a correlation between the severity of
neurodegeneration and the presence of insoluble hyper- Bender, 2000). Both wild-type and mutant presenilins
cause apoptosis in Drosophila (Fortini and Bonini, 2000).phosphorylated tau. Although Feany and coworkers
(Wittmann et al., 2001) did not observe NFT in their In this context, it is perhaps more useful to view Dro-
sophila paradigms employing misexpression of disease-model, the accumulation of nonfilamentous, abnormally
phosphorylated tau was sometimes associated with associated proteins as genetically sensitized systems
for identifying candidate modifiers rather than strictlyvacuoles and degenerating cells. This observation, in
conjunction with the retinal degeneration observed with as models for dominantly acting gain-of-function disor-
ders. Fly models, such as those reported here and else-tau expression alone, suggests that neurotoxicity is due
Tau Interacts with wingless Pathway in Drosophila
517
blotted with T14 or AT100. Immunoblots were developed with perox-where, may yield important clues regarding disorders
idase-conjugated secondary antibody and enhanced chemilumines-of tau dysregulation (including AD) in addition to the
cence (Pierce) and quantified using a laser scanning densitometerrarer cases of FTDP-17 cases caused by tau mutations.
(Molecular Dynamics). The remaining protein was used for extraction
with N-lauroylsarcosinate and EM analysis using phosphotungstate
Experimental Procedures negative staining similar to Goedert et al. (1992). Micrographs were
recorded on a JEOL TEM at an operating voltage of 80 KV with a
Genetics nominal magnification of 19,000.
A cDNA encoding wild-type htau4R was subcloned into the pEx-
press-gl modification (Ollmann et al., 2000) of the GMR expression
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